Director Caren Deardorf filed an initial statement of beneficial ownership with the SEC on November 13, 2026, disclosing no securities held in Alpha Cognition Inc. as of the event date of November 11, 2026.

Key Highlights

  • Reporting person: Caren Deardorf, identified as a Director of Alpha Cognition Inc.
  • Event date: November 11, 2026, the date requiring the initial ownership statement.
  • No securities held: The filing explicitly states "No securities are beneficially owned" in both Table I (non-derivative) and Table II (derivative securities).
  • Filing date: The statement was signed by Caren Deardorf and submitted on November 13, 2026.
  • Issuer: Alpha Cognition Inc., trading on NASDAQ:ACOG, a biopharmaceutical company based in Grapevine, Texas.

Alpha Cognition Director Deardorf Reports No Beneficial Ownership at Appointment

Alpha Cognition Inc. (NASDAQ:ACOG) is a biopharmaceutical company whose registered address in this filing is listed as 1452 Hughes Rd., Suite 200, Grapevine, Texas 76051. The initial ownership statement was filed individually, with the form indicating it was filed by one reporting person. Caren Deardorf is listed solely in the capacity of Director, with no officer title or other relationship to the issuer indicated.

According to the filing, both Table I, covering non-derivative securities such as common stock, and Table II, covering derivative securities such as options and warrants, contain no entries. The explanation provided in the filing states: "No securities are beneficially owned." This disclosure reflects Deardorf's ownership position as of November 11, 2026, the date of the event requiring the statement, which typically corresponds to the commencement of a director's status as a reporting person under Section 16(a) of the Securities Exchange Act of 1934.

The filing was submitted individually rather than as a joint or group filing. No amendments to a prior filing are indicated, as this is an initial statement. The form bears Deardorf's signature dated November 13, 2026, two days after the triggering event date.

What Was Disclosed

Caren Deardorf, a newly reporting Director of Alpha Cognition Inc. (NASDAQ:ACOG), filed an initial beneficial ownership statement covering November 11, 2026, disclosing no direct or indirect holdings in either non-derivative or derivative securities of the company.